NCT06852807View on ClinicalTrials.gov

18F-mFBG PET Imaging in the Evaluation of Neuroblastoma

RecruitingOBSERVATIONAL
Enrollment

200

Participants

Timeline

Start Date

February 4, 2025

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions
Neuroblastoma
Interventions
DRUG

18F-MFBG

Patients with neuroblastoma malignancies receive 5.55 MBq/kg of 18F-MFBG intravenously followed by PET/CT or PET/MR after 60min of injection.

Trial Locations (1)

310003

RECRUITING

The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

All Listed Sponsors
lead

First Affiliated Hospital of Zhejiang University

OTHER